Pace Life Sciences LLC, a U.S.-based contract research, development, and manufacturing organization (CRDMO) and a Division of ...

From being a promising yet underexplored approach in the 1990s, mRNA therapeutics have evolved dramatically. The discovery of ...

The "Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions Training Course" training has been added to ResearchAndMarkets.com's offering. Every biotech product ...

Avid Bioservices, Inc. (NASDAQ: CDMO) ("Avid" or the "Company"), a dedicated biologics contract development and manufacturing organization ("CDMO") working ...

Jubilant Ingrevia Ltd (BOM:543271) reports robust year-on-year growth with significant contributions from specialty chemicals and nutrition businesses, despite challenges in the acetyl segment.

"We thank our stockholders for their support through our time as a public company and the duration of this process,” said Nick Green, president and CEO of Avid Bioservices. "We look forward to ...

Avid Bioservices ( ($CDMO) ) has provided an update. On January 30, 2025, Avid Bioservices held a special meeting of stockholders where they ...

Jubilant Ingrevia has announced the commissioning of its new cGMP compliant facility at Bharuch, Gujarat. The new facility, which has a capacity of 5,000 metric tonnes, will manufacture nutraceuticals ...

Jubilant Ingrevia today announced the commissioning of its new cGMP compliant facility at Bharuch, Gujarat. The new facility will manufacture Nutraceuticals and Dietary-Active ingredients for human ...

The industry is grappling with significant market shifts amidst emerging technologies and changing demands. Companies are now ...